Houston Methodist Research Institute presents:

Joseph Gold, Ph.D.

Assistant Director
Translational Research
Stanford University Cardiovascular Institute
Stanford, California

Regenerative medicine seeks to replace lost or damaged organs and tissues with new functional cells which are derived from either the introduction of replacement cells or by inducing regeneration from a patient’s own reserve stem cells.  A number of different cell sources are currently being explored in the clinic for their ability to restore lost function, however, the mechanisms through which they are proposed to act are obscure and the evidence for their efficacy is controversial.  Pluripotent stem cells, embryonic stem cells and induced pluripotent stem cells (iPSCs), have the demonstrated capacity to form all normal cell types. And, in the case of iPSCs they are exact immunological matches to the patient.  \

In this lecture, Dr. Gold will explore the evidence for practicality of pluripotent stem cells in regenerative medicine, describe the current landscape, identify unmet challenges, and distinguish those approaches which are most likely to succeed.   

ACCREDITATION AND CREDIT DESIGNATION STATEMENTS

Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Houston Methodist designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

REGISTER NOW for CME